Our Firm is actively filing Xarelto lawsuits that put forth similar allegations regarding the marketing tactics used to drive sales of the drug. We look forward to the Panel’s decision on the proposed multidistrict litigation.
New York, New York (PRWEB) November 12, 2014
Xarelto lawsuit (http://www.xareltolawsuit2015.com/) plaintiffs have responded to objections raised by the blood thinner’s manufacturers over the proposed creation of a multidistrict litigation for all federally-filed product liability claims involving the medication, Bernstein Liebhard LLP reports. According to court documents, Bayer Healthcare and Johnson & Johnson’s Janssen Pharmaceuticals unit have asserted that the proposed consolidation is inappropriate because the pending lawsuits are too individualized. But in a brief submitted to the U.S. Judicial Panel on Multidistrict Litigation (JPML) on November 7th, plaintiffs point out that all of the complaints raise common questions about the companies’ marketing materials for Xarelto, particularly claims that the drug is superior to warfarin because it does not require patients to undergo regular blood monitoring. (In Re: Xarelto Products Liability Litigation, No. 2592)
“Our Firm is actively filing Xarelto lawsuits that put forth similar allegations regarding the marketing tactics used to drive sales of the drug. We look forward to the Panel’s decision on the proposed multidistrict litigation,” said Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices. The Firm is currently offering free, no-obligation Xarelto case reviews to people who allegedly suffered serious injuries from the blood thinner, including uncontrollable bleeding, strokes, deep vein thrombosis or pulmonary embolism.
Xarelto Lawsuit Allegations
Court records indicate that at least 30 Xarelto lawsuits have been filed in U.S. courts on behalf of individuals who suffered uncontrollable bleeding and other serious complications allegedly linked to its use. Among other things, plaintiffs assert that the manufacturers of the medication should have recommended blood monitoring for patients, so that physicians could adjust dosage to avoid high concentrations that have the potential to lead to life-threatening internal hemorrhaging. The lawsuits also point out that there currently exists no approved antidote for Xarelto bleeding. By contrast, the bleeding that can occur with warfarin can be stopped via the administration of vitamin K.
In October, a number of Xarelto lawsuit plaintiffs asked the JPML to consolidate all federally-filed claims before a single judge in the U.S. District Court, Southern District of Illinois for coordinated pretrial proceedings. According to court documents, the plaintiffs assert that hundreds of cases involving similar allegations could eventually be filed, and that centralization of the docket would allow the Xarelto claims to proceed more efficiently through the court system. The JPML is scheduled to hear Oral Arguments on the matter on December 4, 2014.
Xarelto patients who were allegedly harmed by the blood thinner may be entitled to recover compensation for medical bills, lost wages, pain and suffering, and more. To learn more about filing a Xarelto lawsuit, please visit Bernstein Liebhard LLPs website, or call 800-511-5092 to schedule a free, no obligation case review.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993. As a national law firm, Bernstein Liebhard LLP possesses all of the legal and financial resources required to successfully challenge billion dollar pharmaceutical and medical device companies. As a result, our attorneys and legal staff have been able to recover more than $3 billion on behalf of our clients. The Firm has been named by The National Law Journal to the Plaintiffs Hot List, recognizing the top plaintiffs firms in the country, for the past 12 consecutive years. Bernstein Liebhard LLP is the only firm in the country to be named to this prestigious list every year since it was first published in 2003.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2014 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, 800-511-5092. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Felecia L. Stern, Esq.
Bernstein Liebhard LLP